Poultry Vaccine Market - Forecasts from 2022 to 2027

The global poultry vaccine market was evaluated at around US$2,018.029 million during the year 2020 and is expected to grow at a CAGR of 1.58% to reach a market value of US$2,251.331 million by 2027.

The growth of this market is primarily attributed to the rapidly growing poultry production across the globe coupled with the growing incidence of several diseases among poultry. According to the United Nations Food and Agriculture Organization (UN FAO), poultry meat production was forecasted to increase by 3 percent in 2019 from 125 million metric tons in 2018. In Europe, between February 16, 2019, and August 15, 2019, two low pathogenic avian influenzas (LPAI) A(H5N1) outbreaks along with one LPAI A(H7N7) outbreak in poultry in Denmark and one LPAI A(H7N3) outbreak in poultry in Italy were reported. As people are consuming more poultry-related food products, rising awareness about the harmful impact of the consumption of diseased poultry food products on human health is further pressurizing poultry manufacturers to vaccinate their poultry regularly, thus positively impacting the global poultry vaccine market growth. Governments and global organizations also create more awareness about animal health and good animal husbandry practices. Increasing poultry healthcare expenditure in major regions and/or countries is also spurring the growth of the global poultry vaccine market during the forecast period. There have been collaborative strategic initiatives and programs to help promote the adoption of poultry vaccines, thereby driving the overall global poultry vaccine market growth. Technological advancements for the manufacturing of new vaccines, coupled with increasing investments in research and development by global market players, will continue to fuel the growth of the global poultry vaccine market during the next five years.

The global poultry vaccine market has been segmented as disease type and product geography. By disease type, the global poultry vaccine market has been classified as avian influenza, Marek’s Disease, bronchitis, and others. The global poultry vaccine market has been segmented by product as inactivated vaccines, attenuated live vaccines, recombinant vaccines, and others.

By geography, North America holds a significant share in the global poultry vaccine market

By geography, the global poultry vaccine market is classified into five major regional markets- North America, South America, Europe, the Middle East and Africa (MEA), and Asia Pacific (APAC). North America accounted for a significant share of the global poultry vaccine market in 2019. Increasing consumption of poultry-related food products has boosted poultry production in the region. According to the United Nations Food and Agriculture Organization (FAO), the United States is the largest producer of poultry meat globally, holding 18.0 percent of the global output. As per statistics of the Government of Canada, Canadian chicken production generated $2.8 billion in 2019, contributing 4.3 percent of cash receipts to farming operations. As of 2019, the country has 2,821 regulated chicken producers, along with nearly 4,756 commercial poultry and egg producers. High concerns about the safety of poultry food products due to the rising incidence of avian diseases are augmenting the demand for poultry vaccines in the region. Moreover, the presence of global market players in the region also contributes to the growth of poultry vaccines. The European poultry vaccine market is anticipated to witness a noteworthy compound annual growth rate during the forecast period on account of high investments in R&D and strict regulations regarding animal husbandry practices. According to the European Commission’s report “Short-Term Outlook for EU agricultural markets in 2019 and 2020”, the EU’s poultry production was projected to rise by 2.5 percent in 2019 due to good demand and high prices. Asia Pacific's (APAC) regional poultry vaccine market was also projected to grow at a noteworthy CAGR between 2019 and 2025 on account of growing poultry production in countries like China and India, coupled with increasing awareness about various poultry diseases. Governments are conducting various poultry health awareness programs. Moreover, market players are expanding their reach in this region to capture a larger share of the global poultry vaccine market, thereby driving the market growth.

Recent Developments

In May 2021, Boehringer Ingelheim India announced the launch of VAXXITEK ® HVT+IBD, a poultry vaccine. VAXXITEK ® HVT+IBD is a novel recombinant vaccine that provides life-long protection for all types of producing hens, including broiler, layer, and breeder chickens.

In October 2020 Boehringer Ingelheim Animal Health launched VAXXITEK®HVT+IBD+ILT, an innovative poultry vaccine. This vaccine is first-of-its-kind and can protect poultry from three diseases- Marek’s Disease, Infectious Laryngotracheitis, and Infectious Bursal Disease.

In April 2020 CEVA Animal Health Inc. plans to build a new chicken vaccine manufacturing facility north of the Guelph auto mall (Canada).

In April 2020 Kemin Industries and Pacific GeneTech signed an exclusive agreement to commercialize a poultry salmonella vaccine. The vaccine can be administered orally or through injection in live and inactive forms. The partnership will focus on registering the vaccine first in the European Union and then in the U.S., Southeast Asia, and Africa.

COVID-19 Impact

The COVID-19 pandemic had a negative influence on the poultry sector, resulting in lower demand, lower sales, unsold stockpiles, and lower poultry meat and egg prices. In nations with substantial poultry populations, such as India, the effect was more pronounced. Although egg, dairy, and meat manufacturing were included in critical services, the supply chain was affected by the lockdown and transportation restrictions. The COVID-19 pandemic, on the other hand, has created chances for vaccine producers to acquire market share.

Market Players and Competitive Intelligence

Prominent key market players in the global poultry vaccine market include Zoetis, Boehringer Ingelheim, Ceva, Merck Animal Health, a subsidiary of Merck & Co., Inc., AniCon Labor GmbH, Hester Biosciences Limited, Elanco, Biovac, Phibro Animal Health Corporation, Salfarm Danmark A/S, and AniCon Labor GmbH. These companies hold a noteworthy share in the market on account of their good brand image and product offerings. Major players in the global poultry vaccine market have been covered, along with their relative competitive position and strategies. The report also mentions recent deals and investments of different market players over the last two years.

Segmentation

By Disease Type

• Avian Influenza
• Marek’s Disease
• Bronchitis

By Product

• Inactivated Vaccines
• Attenuated Live Vaccines
• Recombinant Vaccines

By Geography

• North America
• USA
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Europe
• Germany
• France
• United Kingdom
• Spain
• Middle East and Africa
• Saudi Arabia
• UAE
• South Africa
• Asia Pacific
• China
• Japan
• India
• South Korea
• Australia